Tags

Type your tag names separated by a space and hit enter

[Treatment of chronic arterial circulatory disorders. Double blind trial with Trental 400 (author's transl)].
MMW Munch Med Wochenschr. 1976 Oct 22; 118(43):1399-1402.MM

Abstract

For the objective determination of its efficacy, Trental 400 was examined against placebo in a double blind trial in 40 patients with chronic peripheral circulatory disorders and concomitant symptoms of cerebro-vascular insufficiency typical of age. Treatment lasted 7 to 8 weeks with a dosage of 1 tablet 3 times a day. Trental 400 was significantly more effective than placebo in the treatment of peripheral and cerebral disorders. The preparation was well tolerated, subjectively and objectively.

Authors

No affiliation info available

Pub Type(s)

Clinical Trial
Controlled Clinical Trial
English Abstract
Journal Article

Language

ger

PubMed ID

825745

Citation

Kellner, H. "[Treatment of Chronic Arterial Circulatory Disorders. Double Blind Trial With Trental 400 (author's Transl)]." MMW, Munchener Medizinische Wochenschrift, vol. 118, no. 43, 1976, pp. 1399-1402.
Kellner H. [Treatment of chronic arterial circulatory disorders. Double blind trial with Trental 400 (author's transl)]. MMW Munch Med Wochenschr. 1976;118(43):1399-1402.
Kellner, H. (1976). [Treatment of chronic arterial circulatory disorders. Double blind trial with Trental 400 (author's transl)]. MMW, Munchener Medizinische Wochenschrift, 118(43), 1399-1402.
Kellner H. [Treatment of Chronic Arterial Circulatory Disorders. Double Blind Trial With Trental 400 (author's Transl)]. MMW Munch Med Wochenschr. 1976 Oct 22;118(43):1399-1402. PubMed PMID: 825745.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Treatment of chronic arterial circulatory disorders. Double blind trial with Trental 400 (author's transl)]. A1 - Kellner,H, PY - 1976/10/22/pubmed PY - 1976/10/22/medline PY - 1976/10/22/entrez SP - 1399 EP - 1402 JF - MMW, Munchener medizinische Wochenschrift JO - MMW Munch Med Wochenschr VL - 118 IS - 43 N2 - For the objective determination of its efficacy, Trental 400 was examined against placebo in a double blind trial in 40 patients with chronic peripheral circulatory disorders and concomitant symptoms of cerebro-vascular insufficiency typical of age. Treatment lasted 7 to 8 weeks with a dosage of 1 tablet 3 times a day. Trental 400 was significantly more effective than placebo in the treatment of peripheral and cerebral disorders. The preparation was well tolerated, subjectively and objectively. SN - 0341-3098 UR - https://www.unboundmedicine.com/medline/citation/825745/[Treatment_of_chronic_arterial_circulatory_disorders__Double_blind_trial_with_Trental_400__author's_transl_]_ DB - PRIME DP - Unbound Medicine ER -